HCPCS Level IIdrugActive

J1576

Inj, panzyga, 500 mg

BETOS: O1E

Effective: 2023-07-01

Referenced in 8 policies

Description

Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg

Medicare Part B Drug Pricing

Average Sales Price (ASP) data for Q1 2026

Drug Name

Panzyga

Manufacturer

Pfizer Inc

HCPCS Dosage

500 MG

Billing Units

5.0000

NDC Products

asp

Pricing Source

Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.